GSK plc Stock: Today’s News, Analyst Forecasts, and the Biggest Catalysts Heading Into 2026 (Dec. 22, 2025)
GSK shares last traded at $48.61 on the NYSE. On Dec. 19, the Trump administration announced a drug-pricing deal with GSK tied to tariff relief and lower prices for certain respiratory drugs. The FDA approved GSK’s Exdensur for severe asthma on Dec. 16, marking the first twice-yearly biologic in its category.